Table 3.
Prevalence of metabolic syndrome stratified by age and sex among the study participants
| Age (years) | Modified ATP III criteria | IFD criteria | Harmonised definition | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | Total | Male | Female | Total | Male | Female | Total | ||||||||||
| n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
| 40–49 (n 1835) | 219 | 34·7 | 400 | 33·3 | 619 | 33·7 | 164 | 25·9 | 364 | 30·3 | 528 | 28·8 | 266 | 42·1 | 400 | 33·3 | 666 | 36·3 |
| 50–59 (n 3041) | 391 | 35·2 | 942 | 48·8 | 1333 | 43·8 | 258 | 23·2 | 836 | 43·3 | 1094 | 36·0 | 470 | 42·3 | 942 | 48·8 | 1412 | 46·4 |
| 60–69 (n 3334) | 414 | 29·8 | 1066 | 54·9 | 1480 | 44·4 | 277 | 19·9 | 949 | 48·8 | 1226 | 36·8 | 512 | 36·8 | 1066 | 54·9 | 1578 | 47·3 |
| 70–79 (n 1314) | 133 | 21·7 | 374 | 53·4 | 507 | 38·6 | 88 | 14·4 | 330 | 47·1 | 418 | 31·8 | 181 | 29·5 | 374 | 53·4 | 555 | 42·2 |
| 80+ (n 266) | 29 | 24·2 | 72 | 49·3 | 101 | 38·0 | 21 | 17·5 | 58 | 39·7 | 79 | 29·7 | 33 | 27·5 | 72 | 49·3 | 105 | 39·5 |
| Overall (n 9790) | 1186 | 30·7 | 2854 | 48·2 | 4040 | 41·3 | 808 | 20·9 | 2537 | 42·8 | 3345 | 34·2 | 1462 | 37·8 | 2854 | 48·2 | 4316 | 44·1 |
| ASSR* | 32·4 | 44·2 | 38·2 | 22·7 | 39·3 | 30·9 | 39·6 | 44·2 | 41·8 | |||||||||
ASSR = age- and sex-standardised rates.
Percentages represent the number of subjects with metabolic syndrome among the total number of subjects; data are presented as n (%).
*
ASSRs by China census population 2010.